Search tips
Search criteria 


Logo of molmedLink to Publisher's site
Mol Med. 1999 November; 5(11): 743–752.
PMCID: PMC2230486

Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.


BACKGROUND: There is increasing evidence showing that extracellular nucleosides [corrected] may be important mediators of vascular inflammation. Nucleoside [corrected] triphosphate diphosphohydrolase-1 (NTPDase-1, identical to CD39), the major vascular endothelial ectonucleotidase, is responsible for the hydrolysis of both extracellular ATP and ADP in the blood plasma to AMP. Studies were therefore conducted to evaluate the role of vascular NTPDase-1/cd39 in modulating platelet activation and vascular injury in cardiac xenografts. MATERIALS AND METHODS: Cardiac xenografts from both wild-type and cd39 knockout mice (C57BL/6 x 129 Svj) were transplanted into Lewis rats. Alterations in cd39 mRNA transcripts and NTPDase activity expression were evaluated in wild-type grafts in untreated rats and then following complement depletion and immunosuppression. Rejection responses were studied with both mutant and wild-type grafts in the following models: presensitization with or without complement depletion, complement depletion alone, and with chronic immunosuppression to induce long-term graft survival. RESULTS: NTPDase biochemical activity in wild-type xenografts rapidly decreased after transplantation but soon rebounded with graft survival. Elevated levels of cd39 mRNA with associated increases in NTPDase activity were observed in all long-term surviving wild-type grafts. Hyperacute xenograft rejection times were comparable in wild-type and mutant grafts but cd39-deficient grafts were subject to more rapid rejection and exhibited pronounced vascular injury in complement-depleted, presensitized rats. The cd39-deficient grafts in immunosuppressed recipients were subject to increased intravascular platelet sequestration and fibrin deposition; this resulted in focal myocardial infarction in long-term surviving mutant xenografts. CONCLUSIONS: Augmentation of NTPDase-1 activity may be an important adaptive response for graft survival. Our results suggest that NTPDase-1/cd39 influences pathways of vascular injury in cardiac xenografts.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, Vanhove B, Blakely ML, van der Werf WJ, Hofer E, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev. 1994 Oct;141:5–30. [PubMed]
  • Robson SC, Candinas D, Hancock WW, Wrighton C, Winkler H, Bach FH. Role of endothelial cells in transplantation. Int Arch Allergy Immunol. 1995 Apr;106(4):305–322. [PubMed]
  • Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today. 1996 Aug;17(8):379–384. [PubMed]
  • Bach FH. Xenotransplantation: problems and prospects. Annu Rev Med. 1998;49:301–310. [PubMed]
  • Robson SC, Young VK, Cook NS, Metternich R, Kasper-Konig W, Lesnikoski BA, Pierson RN, 3rd, Hancock WW, Candinas D, White DJ, et al. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation. 1996 Mar 27;61(6):862–868. [PubMed]
  • Robson SC, Schulte am Esch J, 2nd, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci. 1999 Jun 18;875:261–276. [PubMed]
  • Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem. 1996 Dec 20;271(51):33116–33122. [PubMed]
  • Côté YP, Picher M, St-Jean P, Béliveau R, Potier M, Beaudoin AR. Identification and localization of ATP-diphosphohydrolase (apyrase) in bovine aorta: relevance to vascular tone and platelet aggregation. Biochim Biophys Acta. 1991 Jun 24;1078(2):187–191. [PubMed]
  • Lüthje J. Origin, metabolism and function of extracellular adenine nucleotides in the blood. Klin Wochenschr. 1989 Mar 15;67(6):317–327. [PubMed]
  • Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol. 1995;158:141–214. [PubMed]
  • Zimmermann H. 5'-Nucleotidase: molecular structure and functional aspects. Biochem J. 1992 Jul 15;285(Pt 2):345–365. [PubMed]
  • Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C, et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol. 1994 Oct 15;153(8):3574–3583. [PubMed]
  • Wang TF, Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem. 1996 Apr 26;271(17):9898–9901. [PubMed]
  • Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest. 1991 Nov;88(5):1690–1696. [PMC free article] [PubMed]
  • Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest. 1997 Mar 15;99(6):1351–1360. [PMC free article] [PubMed]
  • Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS, 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999 Sep;5(9):1010–1017. [PubMed]
  • Pearson JD, Gordon JL. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature. 1979 Oct 4;281(5730):384–386. [PubMed]
  • Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today. 1995 Nov;16(11):524–528. [PubMed]
  • Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol. 1997 Aug 1;159(3):1451–1458. [PubMed]
  • Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 1993 Apr 1;7(6):516–522. [PubMed]
  • Chinellato A, Froldi G, Caparrotta L, Ragazzi E. Pharmacological characterization of endothelial cell nitric oxide synthase inhibitors in isolated rabbit aorta. Life Sci. 1998;62(6):479–490. [PubMed]
  • Simonsen U, García-Sacristán A, Prieto D. Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries. Br J Pharmacol. 1997 Feb;120(3):411–420. [PMC free article] [PubMed]
  • Rongen GA, Floras JS, Lenders JW, Thien T, Smits P. Cardiovascular pharmacology of purines. Clin Sci (Lond) 1997 Jan;92(1):13–24. [PubMed]
  • Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW. Barriers to xenotransplantation. Nat Med. 1995 Sep;1(9):869–873. [PubMed]
  • Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation. 1994 Nov 27;58(10):1059–1066. [PubMed]
  • Candinas D, Koyamada N, Miyatake T, Siegel J, Hancock WW, Bach FH, Robson SC. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost. 1996 Nov;76(5):807–812. [PubMed]
  • Robson SC, Daoud S, Bégin M, Côté YP, Siegel JB, Bach FH, Beaudoin AR. Modulation of vascular ATP diphosphohydrolase by fatty acids. Blood Coagul Fibrinolysis. 1997 Jan;8(1):21–27. [PubMed]
  • Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med. 1997 Jan 6;185(1):153–163. [PMC free article] [PubMed]
  • Robson SC, Candinas D, Siegel JB, Kopp C, Millan M, Hancock WW, Bach FH. Potential mechanism of abnormal thromboregulation in xenograft rejection: loss of ecto-ATPases upon endothelial cell activation. Transplant Proc. 1996 Apr;28(2):536–536. [PubMed]
  • Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, Winkler H, Badrichani A, Candinas D, Hancock WW. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med. 1997 Feb;3(2):196–204. [PubMed]
  • Koyamada N, Miyatake T, Candinas D, Mark W, Hechenleitner P, Hancock WW, Soares MP, Bach FH. Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts. Transplantation. 1998 May 15;65(9):1210–1215. [PubMed]
  • Sévigny J, Levesque FP, Grondin G, Beaudoin AR. Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques. Biochim Biophys Acta. 1997 Feb 11;1334(1):73–88. [PubMed]
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. [PubMed]
  • Baykov AA, Evtushenko OA, Avaeva SM. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem. 1988 Jun;171(2):266–270. [PubMed]
  • Imai M, Kaczmarek E, Koziak K, Sévigny J, Goepfert C, Guckelberger O, Csizmadia E, Schulte Am Esch J, 2nd, Robson SC. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells. Biochemistry. 1999 Oct 12;38(41):13473–13479. [PubMed]
  • Schulte am Esch J, 2nd, Sévigny J, Kaczmarek E, Siegel JB, Imai M, Koziak K, Beaudoin AR, Robson SC. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry. 1999 Feb 23;38(8):2248–2258. [PubMed]
  • Koyamada N, Miyatake T, Candinas D, Hechenleitner P, Siegel J, Hancock WW, Bach FH, Robson SC. Apyrase administration prolongs discordant xenograft survival. Transplantation. 1996 Dec 27;62(12):1739–1743. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ